UA97944C2 - Compounds for treating inflammatory diseases - Google Patents

Compounds for treating inflammatory diseases

Info

Publication number
UA97944C2
UA97944C2 UAA200713025A UAA200713025A UA97944C2 UA 97944 C2 UA97944 C2 UA 97944C2 UA A200713025 A UAA200713025 A UA A200713025A UA A200713025 A UAA200713025 A UA A200713025A UA 97944 C2 UA97944 C2 UA 97944C2
Authority
UA
Ukraine
Prior art keywords
compounds
inflammatory diseases
treating inflammatory
diseases
relates
Prior art date
Application number
UAA200713025A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Райнер Вальтер
Ральф Андерскевитц
Йорг Клей
Хорст Доллингер
Рольф Гьоггель
Биргит Юнг
Юрген Мак
Петер Николаус
Original Assignee
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Интернациональ Гмбх filed Critical Берингер Ингельхайм Интернациональ Гмбх
Priority claimed from PCT/EP2006/061586 external-priority patent/WO2006114371A1/en
Publication of UA97944C2 publication Critical patent/UA97944C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to novel compounds of formula (1), heteroderivatives thereof, and pharmacologically compatible salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, that are suitable for treating respiratory or gastrointestinal complaints or illnesses, inflammatory diseases of the joints, skin or eyes, diseases relating to the peripheral or central nervous system, or cancerous diseases. The invention also relates to pharmaceutical compositions containing said compounds.1,
UAA200713025A 2005-04-28 2006-04-13 Compounds for treating inflammatory diseases UA97944C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005019718A DE102005019718A1 (en) 2005-04-28 2005-04-28 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
PCT/EP2006/061586 WO2006114371A1 (en) 2005-04-28 2006-04-13 Novel compounds for treating inflammatory diseases

Publications (1)

Publication Number Publication Date
UA97944C2 true UA97944C2 (en) 2012-04-10

Family

ID=37310878

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200713025A UA97944C2 (en) 2005-04-28 2006-04-13 Compounds for treating inflammatory diseases

Country Status (4)

Country Link
CN (1) CN101166723A (en)
DE (1) DE102005019718A1 (en)
UA (1) UA97944C2 (en)
ZA (1) ZA200707592B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262232B (en) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 The preparation method of Ni Taidani
CN104844499B (en) * 2015-06-05 2017-03-08 北京康立生医药技术开发有限公司 One kettle way prepares the synthetic method of Nintedanib
CN106278831B (en) * 2015-06-10 2019-08-09 联化科技（台州）有限公司 The preparation method and intermediate of 2- phenethyl phenol derivatives and its intermediate

Also Published As

Publication number Publication date
ZA200707592B (en) 2008-10-29
CN101166723A (en) 2008-04-23
DE102005019718A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
UA93872C2 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
MX2008012915A (en) Dihydrothienopyrimidine for treating inflammatory disorders.
UA99309C2 (en) Substituted piperidino-dihydrothienopyrimidines
TW200635597A (en) Substituted pteridines for the treatment of inflammatory diseases
TW200631583A (en) Substituted pteridines for the treatment of inflammatory diseases
MX2007006357A (en) Substituted pteridines for treating inflammatory diseases.
ATE549338T1 (en) SUBSTITUTED PTERIDINES SUBSTITUTED WITH A FOUR-MEMBER HETEROCYCLE
HK1094425A1 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
WO2006058867A3 (en) Substituted pteridines for the treatment of inflammatory diseases
EA200901373A1 (en) AMINOGETEROCYCLIC COMPOUNDS
MX2010003346A (en) Heterocycle-substituted piperazino-dihydrothienopyrimidines.
HRP20070505B1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
WO2007135026A3 (en) Substituted pteridines as therapeutic agents
DE602006020295D1 (en) AZABENZIMIDALZOL DERIVATES, THEIR PREPARATION AND THEIR USE AS ANTICROBIAL AGENTS
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
TW200724143A (en) Novel compounds for the treatment of inflammatory diseases
MY146802A (en) Novel drugs for treating respiratory diseases
GB0519760D0 (en) Novel compounds
UA97944C2 (en) Compounds for treating inflammatory diseases
TW200606148A (en) Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
TW200603801A (en) Novel dialkoxy-imidazopyridines
TW200613301A (en) Novel amino-halogen-imidazopyridines
TN2010000373A1 (en) The present invention provides oxadiazoanthracene